US hospital-backed Civica Rx, a non-profit generic pharmaceutical company which just celebrated its one-year anniversary, has delivered the first drug under its disruptive business model aiming at fixing the nation’s problem of drug shortages and soaring prices.
Civica’s shipment of Xellia’s vancomycin hydrochloride, a crucial antibiotic often in short supply in medical facilities across the US,...




